Michael Ryskin Analyst PerformanceManaging Director at Bank of AmericaMichael Ryskin is a stock analyst at Bank of America in the medical sector, covering 11 publicly traded companies. Over the past year, Michael Ryskin has issued 10 stock ratings, including buy, hold, and sell recommendations. While full access to Michael Ryskin's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Michael Ryskin's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings19 Last 7 YearsBuy Recommendations36.84% 7 Buy RatingsCompanies Covered11 Unique Companies Ratings Distribution19RatingsDistribution of strong buy, buy, hold, and sell ratings by Michael Ryskin.RatingPercentageCount Strong Buy0.0%0 ratings Buy36.8%7 ratings Hold52.6%10 ratings Sell10.5%2 ratingsOut of 19 total stock ratings issued by Michael Ryskin at Bank of America, the majority (52.6%) have been Hold recommendations, followed by 36.8% Buy and 10.5% Sell.Best & Worst CallsBest Call000.0%IDXXJun 2019Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%MRVIMar 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ63.6% of companies on NASDAQ7 companiesNYSE36.4% of companies on NYSE4 companiesMichael Ryskin, an analyst at Bank of America, currently covers 11 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical11 companies100.0%Michael Ryskin of Bank of America specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMEDICAL SERVICES3 companies27.3%MED - DRUGS2 companies18.2%MEDICAL INFO SYS2 companies18.2%MED - BIOMED/GENE1 company9.1%MED PRODUCTS1 company9.1%MED INSTRUMENTS1 company9.1%MED - OUTP/HM CRE1 company9.1% Michael Ryskin's Ratings History at Bank of America Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsLHLabcorp7/13/2026Boost Price Target$278.53$320.00Buy$0.0000.00% ROIGHGuardant Health7/6/2026Boost Price Target$167.98$190.00Buy$0.0000.00% ROIICLRIcon6/25/2026Boost Price Target$158.17$150.00Underperform$0.0000.00% ROIICLRIcon6/1/2026Reiterated Rating$136.07Outperform$0.0000.00% ROIICLRIcon5/27/2026Boost Price Target$113.85$105.00Underperform$0.0000.00% ROIRXRXRecursion Pharmaceuticals2/25/2026Lower Price Target$3.79$6.00Neutral$0.0000.00% ROIZTSZoetis2/13/2026Boost Price Target$125.58$140.00Neutral$0.0000.00% ROISDGRSchrodinger12/15/2025Upgrade$18.05$24.00Buy$0.0000.00% ROIRVTYRevvity12/15/2025Downgrade$98.80$110.00Neutral$0.0000.00% ROIRVTYRevvity9/22/2025Lower Price Target$86.36$99.00Buy$0.0000.00% ROITEMTempus AI6/25/2025Boost Price Target$67.14$70.00Neutral$00.0000.00% ROITEMTempus AI5/20/2025Boost Price Target$63.74$68.00Neutral$00.0000.00% ROIMRVIMaravai LifeSciences3/3/2025Lower Price Target$3.22$8.00Buy$0.0000.00% ROITEMTempus AI3/3/2025Boost Price Target$56.18$60.00Neutral$00.0000.00% ROIIDXXIDEXX Laboratories2/4/2025Boost Price Target$469.04$535.00Neutral$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTruist FinancialPiper SandlerBMO Capital MarketsRaymond James FinancialStifel Nicolaus Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
